CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on novel targeted medicines primarily for cancer treatment, will release its first quarter 2007 financial results on Wednesday, May 2, before the market opens. The Company will also hold a conference call at 10:00 a.m. Eastern on the 2nd to discuss the financial results, progress of its therapeutic product development programs, and additional corporate activities. Daniel Passeri, President and CEO of Curis, will host the call.
